Engineering CAR-NK cells targeting CD33 with concomitant extracellular secretion of anti CD16 antibody revealed superior antitumor effects toward myeloid leukemia https://www.biorxiv.org/content/10.1101/2022.11.14.516308v1?med=mas
Engineering CAR-NK cells targeting CD33 with concomitant extracellular secretion of anti CD16 antibody revealed superior antitumor effects toward myeloid leukemia https://www.biorxiv.org/content/10.1101/2022.11.14.516308v1?med=mas